A Study in Healthy Men to Test the Influence of BI 1323495 on the Amount of the Medicines Rosuvastatin and Dabigatran in the Blood
Clinical trial NCT04257032 · COMPLETED
Trial details
- NCT number
- NCT04257032
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-13
- Primary completion
- 2020-09-23
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.